Illumina Work in process increased by 7.3% to $427.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.7%, from $404.00M to $427.00M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 10.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $278.00M | $286.00M | $333.00M | $340.00M | $366.00M | $387.00M | $386.00M | $404.00M | $415.00M | $423.00M | $402.00M | $405.00M | $416.00M | $419.00M | $404.00M | $404.00M | $419.00M | $418.00M | $398.00M | $427.00M |
| QoQ Change | — | +2.9% | +16.4% | +2.1% | +7.6% | +5.7% | -0.3% | +4.7% | +2.7% | +1.9% | -5.0% | +0.7% | +2.7% | +0.7% | -3.6% | +0.0% | +3.7% | -0.2% | -4.8% | +7.3% |
| YoY Change | — | — | — | — | +31.7% | +35.3% | +15.9% | +18.8% | +13.4% | +9.3% | +4.1% | +0.2% | +0.2% | -0.9% | +0.5% | -0.2% | +0.7% | -0.2% | -1.5% | +5.7% |
| % of Inventories | 73.2% | 71.3% | 65.4% | 62.7% | 61.0% | 59.8% | 58.4% | 58.7% | 57.2% | 57.5% | 56.8% | 57.7% | 60.9% | 60.4% | 61.2% | 62.5% | 60.5% | 58.1% | — | 2135.0% |
| Share Change | — | -1.8pp | -5.9pp | -2.7pp | -1.7pp | -1.2pp | -1.4pp | +0.3pp | -1.5pp | +0.2pp | -0.7pp | +0.9pp | +3.2pp | -0.5pp | +0.8pp | +1.3pp | -2.1pp | -2.3pp | — | — |